{"organizations": [], "uuid": "a38f6f74fb54a2d28607ddda8004af19ac35ff41", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180129.html", "section_title": "Archive News &amp; Video for Monday, 29 Jan 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-raqualia-pharma-plans-pharmaceutic/brief-raqualia-pharma-plans-pharmaceutical-jv-with-zte-coming-biotech-idUSL4N1PO2SN", "country": "US", "domain_rank": 408, "title": "BRIEF-RaQualia Pharma plans pharmaceutical JV with ZTE Coming Biotech", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.873, "site_type": "news", "published": "2018-01-29T15:43:00.000+02:00", "replies_count": 0, "uuid": "a38f6f74fb54a2d28607ddda8004af19ac35ff41"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-raqualia-pharma-plans-pharmaceutic/brief-raqualia-pharma-plans-pharmaceutical-jv-with-zte-coming-biotech-idUSL4N1PO2SN", "ord_in_thread": 0, "title": "BRIEF-RaQualia Pharma plans pharmaceutical JV with ZTE Coming Biotech", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "raqualia pharma inc", "sentiment": "negative"}, {"name": "brief-raqualia pharma", "sentiment": "negative"}, {"name": "beijing headline news", "sentiment": "none"}, {"name": "zte coming biotech", "sentiment": "none"}, {"name": "zte coming biotech co., ltd", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Jan 29(Reuters) - RaQualia Pharma Inc\n* Says it plans to set up a JV, which will be engaged in research and development of pharmaceutical, with Shanghai-based firm ZTE Coming Biotech Co., Ltd, in May\n* Says the company and ZTE Coming Biotech will hold a 35 percent stake and a 65 percent stake in the JV respectively\nSource text in Japanese: goo.gl/mB6hEz\nFurther company coverage: (Beijing Headline News)\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html", "https://goo.gl/mB6hEz"], "published": "2018-01-29T15:43:00.000+02:00", "crawled": "2018-01-30T19:09:16.003+02:00", "highlightTitle": ""}